Quick Answer
Can-Fite BioPharma Ltd. reported Total Assets of $9.51 million for fiscal year 2025.
Can-Fite BioPharma Ltd. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $9.51M | +4.3% |
| 2024 | $9.12M | -8.7% |
| 2023 | $9.99M | +7.6% |
| 2022 | $9.28M | -54.2% |
| 2021 | $20.25M | +112.7% |
| 2020 | $9.52M | +16.5% |
| 2019 | $8.17M | +2.8% |
| 2018 | $7.95M | +4.4% |
| 2017 | $7.61M | — |
- Can-Fite BioPharma Ltd. showed an increase of +4.3% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, Can-Fite BioPharma Ltd.’s total assets has grown by 25.0% (from $7.61 million to $9.51 million).
- The most recent figure is from Can-Fite BioPharma Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: